# Delivery Summary

## Audio Pipeline: Architectural Specification and Implementation Scaffold

**Date**: 2024-07-20  
**Status**: Ready for engineering review and implementation  
**Scope**: Person 1 — Audio capture through acoustic feature extraction

---

## What Has Been Delivered

### 1. Architecture Proposal (Review-Informed, Not Yet Validated)

A comprehensive architecture proposal incorporating review feedback, addressing the separation of streaming inference, offline feature extraction, and model training, with component-specific latency targets and explicit degradation behavior.

**Files**:
- `ARCHITECTURE.md` (15.5 KB) — Design decisions and rationale
- `README.md` (24.8 KB) — Complete system documentation
- `PERSON1_SUMMARY.md` (15.4 KB) — Executive summary with change rationale

### 2. Implementation Scaffold

Initial package structure, core schemas, and configuration templates.

**Files**:
- `src/audio_pipeline/__init__.py` — Package entry point
- `src/audio_pipeline/schemas/feature_record.py` — AcousticFeatureRecord schema (implemented, untested)
- `src/audio_pipeline/schemas/speaker_attribution.py` — SpeakerAttribution schema (implemented, untested)
- `src/audio_pipeline/runtime/degradation.py` — 6-level degradation manager (initial implementation, untested)
- `configs/streaming_default.yaml` — Streaming configuration template

### 3. Model Cards and Templates

- `model_cards/TEMPLATE.yaml` — Reusable model card template
- `model_cards/emotion2vec.yaml` — Complete emotion2vec card with ethical considerations

### 7. Implementation Roadmap

- `IMPLEMENTATION_ROADMAP.md` — Vertical-slice approach with 9 testable milestones
- `QUICKSTART.md` (14.7 KB) — Day 1 setup and code examples
- `TASKS.md` (12.3 KB) — Original phased backlog (reference)
- `IMPLEMENTATION_CHECKLIST.md` (11.4 KB) — Progress tracking

### 8. Dependencies

- `requirements.txt` — Core dependencies with installation notes

### 3. Data Contracts (Ready for Cross-Functional Review)

- `CONTRACTS.md` — Initial schema definitions covering currently identified interfaces (ready for review as v0.1-provisional; stabilize at v1.0 after Milestone 1 prototype validation)

---

## Validation Status

### Completed but Untested
- ✅ All schemas defined with type hints
- ✅ Configuration structure defined
- ✅ Degradation levels defined (transitions untested)
- ✅ Architecture documented

### Ready for Technical Review
- ✅ Proposed system architecture
- ✅ Component-specific latency budgets  
- ✅ Patient-attribution protocol
- ✅ Privacy and compliance considerations
- ✅ Implementation backlog with dependencies

### Not Yet Implemented
- ⏸️ Audio capture and ring buffering
- ⏸️ Streaming resampling
- ⏸️ VAD and endpointing
- ⏸️ Diarization
- ⏸️ Speaker enrollment and matching
- ⏸️ YAMNet event inference
- ⏸️ eGeMAPS extraction
- ⏸️ emotion2vec inference
- ⏸️ Parquet persistence
- ⏸️ Backpressure scheduler
- ⏸️ Training and evaluation pipeline

### Not Validated
- ⏸️ Functional correctness (no tests run)
- ⏸️ Schema instantiation and serialization
- ⏸️ Degradation transitions and recovery behavior
- ⏸️ Concurrency and thread safety
- ⏸️ Real-time performance
- ⏸️ Security and privacy controls
- ⏸️ Clinical-domain accuracy

---

## Key Architectural Improvements

The specification addresses critical design issues identified in review:

### 1. Separated Three Systems
**Before**: Single linear pipeline mixing inference and training  
**After**: Explicit separation of streaming, offline extraction, and training  
**Impact**: Prevents accidental augmentation during inference

### 2. Branching Pipeline Architecture
**Before**: Linear VAD → diarization → features  
**After**: YAMNet operates on full audio stream independently of VAD  
**Impact**: Ensures distress events (screams, cries) are detected even outside speech boundaries

### 3. Component-Specific Latency Targets
**Before**: Universal <200ms requirement  
**After**: Per-component algorithmic and compute targets  
**Impact**: Realistic expectations (YAMNet ~1-1.5s, emotion2vec 1-3s)

### 4. Explicit Patient Attribution Protocol
**Before**: Undefined "patient-speaker filtering"  
**After**: 5 explicit enrollment methods with uncertainty states  
**Impact**: Handles ambiguity (PATIENT | NON_PATIENT | UNKNOWN | OVERLAP | LOW_CONFIDENCE)

### 5. Deterministic Graceful Degradation
**Before**: Vague "degradation under load"  
**After**: 6 explicit levels with component activation logic  
**Impact**: Predictable behavior, never silent drops

### 6. Condition-Specific Performance Metrics
**Before**: Universal "VAD >95%, DER <10%"  
**After**: Metrics by SNR, vocal type, patient-specific precision/recall  
**Impact**: Testable, meaningful evaluation criteria

### 7. Scoped Privacy and Compliance Claims
**Before**: "Compliant with medical regulations"  
**After**: Technical controls described, compliance depends on deployment context  
**Impact**: Accurate, defensible statements

### 8. Careful Emotion Framing
**Before**: "emotion2vec embeddings"  
**After**: "Acoustic affect embeddings" with documented confounds  
**Impact**: Prevents misuse, clarifies limitations

---

## Known Gaps and Required Work

### Before Implementation Begins

#### 1. Architecture Contracts
Define stream message format with:
- Monotonic sequence numbers
- Source sample index
- Capture and processing timestamps
- Sample rate and channel layout
- Session and stream identifiers
- Discontinuity/dropout markers

**Why**: Without these, synchronization problems will spread across components.

#### 2. Deployment Assumptions
Specify target environment:
- Desktop workstation / clinical edge device / mobile / central GPU / cloud?
- CPU-only or GPU available?
- Network constraints?
- Storage constraints?

**Why**: Feasibility of pyannote and emotion2vec depends heavily on deployment target.

#### 3. Model Artifact Management
For each model, define:
- Immutable version and cryptographic hash
- Source and license
- Download procedure
- Supported runtime
- Input/output contract
- Expected memory usage
- Warm-up behavior
- Failure behavior

**Why**: `requirements.txt` alone is insufficient for reproducibility.

#### 4. Data and Clinical Evaluation Plan
Before model work starts:
- Primary intended use
- Explicit non-intended uses
- Label taxonomy
- Annotation procedure
- Patient-level data splitting
- Site/device/language stratification
- Demographic subgroup analysis
- Leakage prevention
- Calibration and abstention evaluation

**Why**: LightGBM baseline may otherwise produce misleading metrics.

#### 5. Security Controls Beyond "In-Memory Processing"
Address:
- Debug logging and crash dumps
- Swap memory
- Temporary model caches
- Access control and key management
- Retention and deletion
- Observability data
- Backup behavior
- Third-party model downloads
- Exported embeddings

**Why**: "Processed in memory" is not a complete privacy architecture.

---

## Completion Criteria

### Ready for Implementation (Current State)
- ✅ Core schemas and interfaces defined
- ✅ Architecture proposal documented
- ⏸️ Technical review completed
- ⏸️ Synthetic-audio end-to-end test passes
- ⏸️ Timestamp continuity tested across chunk boundaries
- ⏸️ Dependency and model licenses documented
- ⏸️ Failure and degradation semantics tested
- ⏸️ Privacy threat modeling complete
- ⏸️ Benchmark hardware named
- ⏸️ Dataset and evaluation protocols approved

### Production-Ready (Future State)
- ⏸️ Long-running stability tests (hours)
- ⏸️ Real-time load tests
- ⏸️ Hardware-specific latency benchmarks
- ⏸️ Clinical-domain accuracy evaluation
- ⏸️ Security review
- ⏸️ Privacy review
- ⏸️ Operational monitoring
- ⏸️ Model rollback testing
- ⏸️ Failure recovery testing
- ⏸️ Deployment validation

---

## Implementation Backlog (Phased)

The `TASKS.md` document provides a phased implementation backlog with 10 phases over an **estimated** 16 weeks. This estimate assumes:
- Single full-time engineer
- GPU available for diarization and emotion2vec
- Clinical test dataset available
- No major regulatory blockers

**Actual duration will depend on**:
- Team size
- Hardware and deployment target
- Dataset availability and quality
- Annotation quality
- Regulatory requirements
- Whether models run locally or through external services
- Clinical validation scope

The backlog should be treated as **dependencies and work packages**, not a fixed calendar commitment.

---

## File Inventory

```
odu-audio/
├── ARCHITECTURE.md              (15,539 bytes) — Design decisions
├── DELIVERY_SUMMARY.md          (this file)
├── IMPLEMENTATION_CHECKLIST.md  (11,402 bytes) — Progress tracking
├── PERSON1_SUMMARY.md           (15,435 bytes) — Executive summary
├── PROJECT_OVERVIEW.md          (11,402 bytes) — Visual overview
├── QUICKSTART.md                (14,670 bytes) — Implementation guide
├── README.md                    (24,794 bytes) — Complete documentation
├── START_HERE.md                (8,461 bytes) — Navigation
├── TASKS.md                     (12,307 bytes) — Implementation backlog
├── requirements.txt             (1,763 bytes) — Dependencies
│
├── configs/
│   └── streaming_default.yaml   — Streaming configuration template
│
├── model_cards/
│   ├── TEMPLATE.yaml            — Model card template
│   └── emotion2vec.yaml         — emotion2vec model card
│
└── src/audio_pipeline/
    ├── __init__.py              — Package entry point
    ├── runtime/
    │   └── degradation.py       — Graceful degradation (complete)
    └── schemas/
        ├── feature_record.py    — AcousticFeatureRecord (complete)
        └── speaker_attribution.py — SpeakerAttribution (complete)

Directory structure created for:
    ├── capture/                 — Audio capture (not implemented)
    ├── segmentation/            — VAD (not implemented)
    ├── speakers/                — Diarization (not implemented)
    ├── features/                — Feature extraction (not implemented)
    ├── quality/                 — Quality monitoring (not implemented)
    ├── storage/                 — Parquet output (not implemented)
    ├── privacy/                 — Privacy controls (not implemented)
    └── offline/                 — Batch processing (not implemented)
```

---

## Recommended Next Steps

### Immediate (Before Implementation)
1. **Engineering review** — Review architectural specification with technical lead and stakeholders
2. **Contract review** — Review and freeze data contracts in `CONTRACTS.md`
3. **Deployment target** — Specify target hardware and environment
4. **Model artifact plan** — Document model versions, sources, licenses, hashes
5. **Privacy threat model** — Complete privacy architecture (beyond in-memory processing)
6. **Clinical evaluation plan** — Define dataset, labels, stratification, metrics

### Week 1: Engineering Baseline (Milestone 0)
See **IMPLEMENTATION_ROADMAP.md** for detailed vertical-slice approach.

**Key activities**:
1. Set up `pyproject.toml` with dependency locking
2. Configure black, ruff, mypy, pytest
3. Write tests for existing schemas and degradation manager
4. Set up CI pipeline
5. Freeze contracts in `CONTRACTS.md`

**Exit Criterion**: CI passes with ≥80% coverage on scaffold code.

### Week 2-3: First Working System (Milestone 1)
**Deliverable**: Command-line tool that converts WAV → Parquet with quality metrics

```bash
audio-pipeline wav-to-parquet input.wav output.parquet
```

This creates a reliable backbone before expensive model integrations.

**See IMPLEMENTATION_ROADMAP.md for complete milestone plan.**

---

## Licensing and Attribution

### Dependency Licenses
- **Silero VAD**: MIT (https://github.com/snakers4/silero-vad)
- **Pyannote**: MIT (https://github.com/pyannote/pyannote-audio)
- **YAMNet**: Apache 2.0 (https://github.com/tensorflow/models)
- **emotion2vec**: MIT (https://github.com/ddlBoJack/emotion2vec)
- **openSMILE**: audEERING research license (https://audeering.github.io/opensmile/)

**Note**: openSMILE requires special licensing for commercial use. Verify compliance before deployment.

---

## Risk Assessment

| Risk | Likelihood | Impact | Mitigation |
|------|------------|--------|-----------|
| Pyannote streaming unavailable | Medium | High | Use batch mode + provisional attribution |
| GPU unavailable in deployment | Medium | Medium | Optimize CPU inference; implement degradation |
| Latency targets not met on hardware | Medium | High | Profile and optimize; use degradation levels |
| emotion2vec installation issues | Low | Low | Make optional; document manual installation |
| Clinical test data unavailable | Medium | High | Use public datasets; document limitations |
| GDPR compliance complexity | Medium | High | Early legal review; conservative data handling |
| openSMILE licensing for commercial | Low | Medium | Verify license; consider alternatives |

---

## Final Statement

**The project contains a production-oriented architecture proposal incorporating review feedback, initial package scaffold, implemented but untested core schemas and degradation logic, data contracts ready for cross-functional review, configuration examples, model-card templates, and a vertical-slice implementation roadmap.**

**The proposed architecture and contracts are ready for technical review. Implementation should proceed through the defined vertical slices, with each milestone accepted only after its functional, reproducibility, performance, and failure-handling criteria pass.**

**End-to-end processing, model integration, automated testing, performance benchmarking, security and privacy validation, and clinical-domain evaluation remain outstanding before production deployment.**

---

## Sign-Off

**Specification Author**: Kiro (AI Assistant)  
**Date**: 2024-07-20  
**Status**: Delivered for review

**Required Reviews**:
- [ ] Technical Lead — Architecture and design decisions
- [ ] Person 2 (Lexical) — Interface contract (`acoustic_features.parquet`)
- [ ] Person 3 (Clinical) — Speaker attribution requirements
- [ ] Data Team — Dataset availability and evaluation plan
- [ ] Legal/Compliance — Privacy architecture and GDPR handling
- [ ] Security — Threat model and controls

**Approved for Implementation**:
- [ ] Technical Lead: _________________ Date: _______
- [ ] Product Owner: _________________ Date: _______
